{"mainPropery":{"diseaseId":1643,"diseaseName":"Cutis verticis gyrata","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/1643/cutis-verticis-gyrata","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"ORPHANET","identifierId":"671"},{"identifierType":"UMLS","identifierId":"C0263417"}]},"diseaseCategories":[{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=(cutis%5BTitle%5D+AND+verticis%5BTitle%5D+AND+gyrata%5BTitle%5D)+AND+(hasabstract%5Btext%5D+AND+%221999%2F08%2F04%22%5BPDat%5D+%3A+%222009%2F07%2F31%22%5BPDat%5D)' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Cutis verticis gyrata. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1113735-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=671' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://dermnetnz.org/dermal-infiltrative/cutis-verticis-gyrata.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:671' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":2407,"questionText":"What is cutis verticis gyrata?","answerText":"<strong>Cutis verticis gyrata</strong> (CVG) refers to deep folds on the scalp that look similar to the folds of the brain.[1507][1508] It occurs more commonly in males, and most commonly develops after puberty, but before age 30. It may occur alone (isolated CVG) or in association with a variety of underlying conditions or treatments, including neuropsychiatric disorders, eye abnormalities, or inflammatory conditions.[1507][1508] While most isolated cases of unknown cause are sporadic, autosomal recessive and autosomal dominant inheritance with varying degrees of severity have been described.&nbsp;In cases associated with underlying conditions, the cause depends on the underlying condition. Management may include keeping areas within the folds clean, and/or surgery if requested for psychological or cosmetic reasons.[1507]","dateModified":"2017-07-27T00:00:00"},"basicQuestions":[{"questionId":7513,"questionText":"What causes cutis verticis gyrata?","answerText":"The underlying cause of cutis verticis gyrate (CVG) is not well understood. The condition may be divided into 3 forms, based on whether it is isolated or it's association with specific underlying conditions:[1507]\r\n<ul>\r\n    <li>Primary essential  - refers to cases in which no other abnormality is present.&nbsp;In this form the cause is not known. While most of these cases appear to be sporadic, autosomal recessive and autosomal dominant inheritance have been described.</li>\r\n    <li>Primary nonessential - can be associated with intellectual disability, cerebral palsy, epilepsy (seizures), schizophrenia, cranial abnormalities (microcephaly), deafness, eye or vision abnormalities, or a combination of these.&nbsp;In this form, the cause may have an endocrinologic basis (caused by abnormalities of the  <a href=\"http://www.nlm.nih.gov/medlineplus/endocrinediseases.html\" target=\"_blank\">endocrine system</a>).</li>\r\n    <li>Secondary - associated with a wide variety of underlying diseases and treatments, which can be viewed <a href=\"http://emedicine.medscape.com/article/1113735-overview#a4\" target=\"_blank\">here on Medscape's website</a>. In these cases, the underlying cause depends on the associated disease or treatment.</li>\r\n</ul>","dateModified":"2017-07-27T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":1507,"authors":"Skibinska MD","articleTitle":"Cutis Verticis Gyrata","bookWebsiteJournalTitle":"Medscape Reference","date":"April 14, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1113735-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7512,"questionText":"How rare is cutis verticis gyrata?","answerText":"The estimated prevalence of cutis verticis gyrata (with data from 1964) is up to 1 in 100,000 people in the general population. It has been estimated to occur in 0.5% (1 in 200) of people with intellectual disability in the United States.[1507]","dateModified":"2017-07-27T00:00:00","resourceClassificationName":"Statistics","references":[{"referenceId":1507,"authors":"Skibinska MD","articleTitle":"Cutis Verticis Gyrata","bookWebsiteJournalTitle":"Medscape Reference","date":"April 14, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1113735-overview","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":45521,"abbreviatedInquiry":"Has there been any research into the reasons why persons with brain injury, seizures, schizophrenia would have cutis verticis gyrata? Has there been any reports of cutis verticis gyrata associated with long-term use of carbamazepine in young men?","caseQuestions":[{"questionId":2407,"questionText":"What is cutis verticis gyrata?","answerText":"<strong>Cutis verticis gyrata</strong> (CVG) refers to deep folds on the scalp that look similar to the folds of the brain.[1507][1508] It occurs more commonly in males, and most commonly develops after puberty, but before age 30. It may occur alone (isolated CVG) or in association with a variety of underlying conditions or treatments, including neuropsychiatric disorders, eye abnormalities, or inflammatory conditions.[1507][1508] While most isolated cases of unknown cause are sporadic, autosomal recessive and autosomal dominant inheritance with varying degrees of severity have been described.&nbsp;In cases associated with underlying conditions, the cause depends on the underlying condition. Management may include keeping areas within the folds clean, and/or surgery if requested for psychological or cosmetic reasons.[1507]","dateModified":"2017-07-27T00:00:00","references":[{"referenceId":1507,"authors":"Skibinska MD","articleTitle":"Cutis Verticis Gyrata","bookWebsiteJournalTitle":"Medscape Reference","date":"April 14, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1113735-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1508,"authors":"Larson F","articleTitle":"Cutis verticis gyrata","bookWebsiteJournalTitle":"DermNet NZ","date":"2007","volume":"","pages":"","url":"http://dermnetnz.org/dermal-infiltrative/cutis-verticis-gyrata.html","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7514,"questionText":"Is there an association between cutis verticis gyrata and epilepsy medication?","answerText":"We were unable to find information regarding an association between cutis verticis gyrata and epilepsy medication in our search.","dateModified":"2014-05-15T13:08:00","references":[]},{"questionId":7513,"questionText":"What causes cutis verticis gyrata?","answerText":"The underlying cause of cutis verticis gyrate (CVG) is not well understood. The condition may be divided into 3 forms, based on whether it is isolated or it's association with specific underlying conditions:[1507]\r\n<ul>\r\n    <li>Primary essential  - refers to cases in which no other abnormality is present.&nbsp;In this form the cause is not known. While most of these cases appear to be sporadic, autosomal recessive and autosomal dominant inheritance have been described.</li>\r\n    <li>Primary nonessential - can be associated with intellectual disability, cerebral palsy, epilepsy (seizures), schizophrenia, cranial abnormalities (microcephaly), deafness, eye or vision abnormalities, or a combination of these.&nbsp;In this form, the cause may have an endocrinologic basis (caused by abnormalities of the  <a href=\"http://www.nlm.nih.gov/medlineplus/endocrinediseases.html\" target=\"_blank\">endocrine system</a>).</li>\r\n    <li>Secondary - associated with a wide variety of underlying diseases and treatments, which can be viewed <a href=\"http://emedicine.medscape.com/article/1113735-overview#a4\" target=\"_blank\">here on Medscape's website</a>. In these cases, the underlying cause depends on the associated disease or treatment.</li>\r\n</ul>","dateModified":"2017-07-27T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":1507,"authors":"Skibinska MD","articleTitle":"Cutis Verticis Gyrata","bookWebsiteJournalTitle":"Medscape Reference","date":"April 14, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1113735-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7512,"questionText":"How rare is cutis verticis gyrata?","answerText":"The estimated prevalence of cutis verticis gyrata (with data from 1964) is up to 1 in 100,000 people in the general population. It has been estimated to occur in 0.5% (1 in 200) of people with intellectual disability in the United States.[1507]","dateModified":"2017-07-27T00:00:00","resourceClassificationName":"Statistics","references":[{"referenceId":1507,"authors":"Skibinska MD","articleTitle":"Cutis Verticis Gyrata","bookWebsiteJournalTitle":"Medscape Reference","date":"April 14, 2016","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1113735-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7515,"questionText":"Are there research studies investigating the cause of cutis verticis gyrata in people with neuropsychiatric disorders?","answerText":"The National Institutes of Health, through the National Library of Medicine, developed <a href=\"http://www.clinicaltrials.gov/\">ClinicalTrials.gov</a>\r\nto provide patients, family members, and members of the public with\r\ncurrent information on clinical research studies. Although no studies\r\ninvolving cutis verticis gyrata are listed at this time, you can check this site\r\noften for updates. To search for a study, use \"cutis verticis gyrata\" as your\r\nsearch term.\r\n<p style=\"margin: 0in 0in 0pt;\">&nbsp;</p>\r\n<p style=\"margin: 0in 0in 0pt;\">You can also contact the Patient\r\nRecruitment and Public Liaison (PRPL) Office at the National Institutes\r\nof Health (NIH). We recommend calling <strong>1-800-411-1222</strong> to speak\r\nwith a specialist, who can help you search for clinical trials.</p>\r\n<p style=\"margin: 0in 0in 0pt;\">&nbsp;</p>\r\n<p style=\"margin: 0in 0in 0pt;\">Patient Recruitment and Public Liaison Office (PRPL)<br />\r\nNIH Clinical Center <br />\r\nBethesda, Maryland 20892-2655<br />\r\nToll-free: 1-800-411-1222<br />\r\nFax: 301-480-9793<br />\r\nE-mail: <a href=\"mailto:prpl@mail.cc.nih.gov\"><span style=\"color: #0000ff;\">prpl@mail.cc.nih.gov</span></a><br />\r\nWeb site:&nbsp; <a href=\"http://clinicalcenter.nih.gov/\">http://clinicalcenter.nih.gov/</a></p>\r\n<p style=\"margin: 0in 0in 0pt;\">&nbsp;</p>\r\n<p style=\"margin: 0in 0in 0pt;\">ClinicalTrials.gov provides a<a href=\"http://www.nih.gov/health/clinicaltrials/basics.htm\"> helpful guide</a> for information about participating in a clinical trial. Resources for <a href=\"http://rarediseases.info.nih.gov/resources/5/support-for-patients-and-families#category17\"><span style=\"color: #0000ff;\">travel and lodging assistance</span></a>\r\nare listed on the National Center for Advancing Translational Sciences\r\nOffice of Rare Diseases Research (NCATS-ORDR) website, part of the\r\nNational Institutes of Health (NIH).</p>","dateModified":"2014-05-15T13:09:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":7349,"phenoTypeName":"Nevus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9339,"phenoTypeName":"Thickened skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9844,"phenoTypeName":"Microcephaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13681,"phenoTypeName":"Aplasia/Hypoplasia of the cerebellum","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13690,"phenoTypeName":"Aplasia/Hypoplasia of the corpus callosum","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5624,"phenoTypeName":"Cataract","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13743,"phenoTypeName":"Cerebral cortical atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11431,"phenoTypeName":"EEG abnormality","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10498,"phenoTypeName":"Strabismus","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Cutis_verticis_gyrata"}